menu
    • menu

    Company profile for Oryzon Genomics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oryzon is a public clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics. From its founding in 2000 through 2008, the company focused its efforts in growing a genomics diagnostics business model, providing genomics services to the pharmaceutical industry in Europe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oryzon GenomicsSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Sant Ferran 74 08940 Cornellà de Llobregat Barcelona
    Telephone
    Telephone
    (+34) 93 515 1313
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oryzon.com/en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ORYZON Reveals December 2025 Shareholders' Meeting Vote Results
    ORYZON Reveals December 2025 Shareholders' Meeting Vote Results

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205459/0/en/ORYZON-Announces-the-Voting-Results-of-December-2025-Extraordinary-General-Shareholders-Meeting.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Oryzon Presents Iadademstat AML Data at 67th ASH Annual Meeting
    Oryzon Presents Iadademstat AML Data at 67th ASH Annual Meeting

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202300/0/en/ORYZON-Presents-Data-for-Iadademstat-Combinations-in-AML-at-the-American-Society-of-Hematology-ASH-67th-Annual-Meeting.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    ORYZON Unveils Q3 2025 Financials & Corporate Progress
    ORYZON Unveils Q3 2025 Financials & Corporate Progress

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183606/0/en/ORYZON-Reports-Financial-Results-and-Corporate-Update-for-Quarter-Ended-September-30-2025.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    ORYZON Reveals Positive Iadademstat Clinical Data At ASH-2025
    ORYZON Reveals Positive Iadademstat Clinical Data At ASH-2025

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180259/0/en/ORYZON-Announces-Positive-Clinical-Data-of-Iadademstat-at-ASH-2025.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    ORYZON Initiates First Patient In Iadademstat Phase Ib Trial
    ORYZON Initiates First Patient In Iadademstat Phase Ib Trial

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179181/0/en/ORYZON-Announces-First-Patient-In-FPI-in-RESTORE-Phase-Ib-Trial-of-Iadademstat-in-Sickle-Cell-Disease.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    ORYZON To Participate In Upcoming Events In November
    ORYZON To Participate In Upcoming Events In November

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177303/0/en/ORYZON-to-Participate-in-Upcoming-Events-in-November.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search